Cat. No. | Product name | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
T79152 | PROTAC EGFR degrader 8 | 2925923-46-0 | 98% |
|
PROTAC EGFR degrader 8 (T-184) is a PROTAC that selectively degrades the epidermal growth factor receptor (EGFR) with a DC50 of 15.56 nM in HCC827 cells. It effe... | ||||
T79293 | EGFR-IN-79 | 98% |
|
|
EGFR-IN-79 (compound 21), an EGFR inhibitor, exhibits antitumor activity through ROS-independent apoptosis and EGFR/AKT/mTOR-mediated autophagy. It effectively i... | ||||
T79297 | DZD1516 | 2387570-00-3 | 98% |
|
DZD1516, a potent and selective HER2 inhibitor (IC50 = 0.56 nM), demonstrates good blood-brain barrier permeability and exhibits antitumor activity in both centr... | ||||
T79327 | EGFR-IN-81 | 98% |
|
|
EGFR-IN-81 (Compound 10i), an EGFR inhibitor, demonstrates potent activity by inhibiting EGFR WT and the L858R/T790M mutation at IC50 values of 4.38 nM and 5.69 ... | ||||
T79368 | Antiproliferative agent-34 | 2910858-34-1 | 98% |
|
Antiproliferative Agent-34 (Compound A14), a multitarget kinase inhibitor, demonstrates IC50 values of 177 nM for EGFR L858R/T790M and 1567 nM for EGFR WT. Addit... | ||||
T79386 | EGFR-IN-84 | 98% |
|
|
EGFR-IN-84 (Compound 6g), an EGFR inhibitor with an IC50 of 24 nM, impedes the growth of A549 cells with an IC50 value of 1.537 μM and is utilized for lung cance... | ||||
T79392 | ALK/EGFR-IN-1 | 2730430-08-5 | 98% |
|
ALK/EGFR-IN-1 (Compound 8l) is a dual inhibitor targeting both ALK and EGFR, effectively blocking their phosphorylation. It demonstrates potent inhibition of ALK... | ||||
T79461 | YK-029A | 2064269-82-3 | 98% |
|
YK-029A, an orally active EGFR mutant inhibitor, targets both EGFR T790M and EGFRex20ins mutations. It demonstrates notable antitumor efficacy, inducing tumor re... | ||||
T79572 | MAPK-IN-2 | 98% |
|
|
MAPK-IN-2 (compound 3h) is an efficacious MAPK inhibitor with antineoplastic properties that significantly hinders proliferation across various cancer cell lines... | ||||
T79651 | EGFR-IN-83 | 98% |
|
|
EGFR-IN-83 (Compound 9), an EGFR inhibitor with an IC50 of 2.53 nM, exhibits antiproliferative effects on MCF-7 and MDA-MB-231 cell lines, with respective IC50 v... | ||||
T79694 | EGFR-IN-88 | 2944452-34-8 | 98% |
|
EGFR-IN-88 (Compound 4i), an EGFR inhibitor with an IC50 of 87 nM, exhibits cytotoxic effects on A549 cells at an IC50 of 3.902 μM and can induce cell apoptosis ... | ||||
T79727 | EGFR/CDK2-IN-2 | 98% |
|
|
EGFR/CDK2-IN-2 (compound 6a) serves as a dual inhibitor targeting both EGFR and CDK-2, exhibiting IC50 values of 19.6 nM and 87.9 nM, respectively. It promotes a... | ||||
T79728 | EGFR/CDK2-IN-3 | 98% |
|
|
EGFR/CDK2-IN-3 (compound 4b) serves as a dual inhibitor targeting both EGFR and CDK-2, exhibiting IC50 values of 71.7 nM and 113.7 nM, respectively. It prompts a... | ||||
T79729 | EGFR/CDK2-IN-4 | 98% |
|
|
EGFR/CDK2-IN-4 (compound 4c) is a dual inhibitor targeting EGFR and CDK-2, demonstrating IC50 values of 89.6 nM for EGFR and 165.4 nM for CDK-2. It prompts apopt... | ||||
T79775 | EGFR-IN-89 | 2413029-40-8 | 98% |
|
EGFR-IN-89 (compound 13k) is a fourth-generation inhibitor selectively targeting EGFR mutations, exhibiting potent activity with an IC50 of 10.1 nM against Del19... | ||||
T79888 | EGFR-IN-87 | 1835666-87-9 | 98% |
|
EGFR-IN-87 is an EGFR tyrosine kinase inhibitor with potent inhibitory activity, exhibiting IC50 values of 3.1 nM, 1.3 nM, and 7.1 nM against EGFR_d746-750, EGFR... | ||||
T80206 | Oligopeptide-41 | 98% |
|
|
Oligopeptide-41 is a bioactive peptide known for its hair growth-promoting effects and is reported to be used as an ingredient in cosmetics [1]. | ||||
T80220 | OK2 | 98% |
|
|
OK2, a specific inhibitor of the CCN2/EGFR interaction, effectively disrupts this interaction by binding to the CT domain of CCN2. It holds potential for use in ... | ||||
T80574 | Becotatug | 2648260-93-7 | 98% |
Becotatug
|
Becotatug (JMT-101) is an IgG1 antibody that targets EGFR and can be conjugated to Afatinib and Osimertinib, functioning as a synthetic antibody-drug conjugate (... | ||||
T80590 | Cinrebafusp alfa | 2218515-90-1 | 98% |
Cinrebafusp alfa
|
Cinrebafusp alfa (PRS 343) is an anticalin-based bispecific drug with high affinity for both CD137/HER2, displaying dissociation constants (Kd) of 0.3 nM to reco... |